Home > Breast > Classic

Breast

Lobular carcinoma

Classic

Authors: Joshua J.X. Li, M.B.Ch.B., Gary M. Tse, M.B.B.S.

Editorial Board Member: Kristen E. Muller, D.O.

Deputy Editor-in-Chief: Gary Tozbikian, M.D.

Last author update: 23 November 2021

Last staff update: 23 November 2021

Copyright: 2002-2023, PathologyOutlines.com, Inc.

PubMed Search: Invasive lobular carcinoma [TI] free full text [SB] "last 5 years"[DP]

Page views in 2022: 47,610

Page views in 2023 to date: 12,186

Table of Contents

Cite this page: Li JJX, Tse GM. Classic. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/breastmalignantlobularclassic.html. Accessed March 22nd, 2023.

Definition / general

Invasive breast carcinoma with loss of cellular adhesion, characteristically arranged in discohesive or single file patterns

Essential features

Special subtype of invasive breast carcinoma characterized by discohesive tumor cells arranged in single files or as individual single cells
Shows 16q loss (CDH1 gene located at 16q22.1 encodes E-cadherin, integral in formation of adherens junction responsible for cell adhesion)
Loss of E-cadherin expression on immunohistochemistry helpful but not required for diagnosis

Terminology

Invasive lobular carcinoma, classic type

ICD coding

ICD-O: 8520/3 - lobular carcinoma, NOS
ICD-11: 2C61.1&XH2XR3 - invasive lobular carcinoma of breast & lobular carcinoma, NOS

Epidemiology

Comprises about 10% of invasive breast carcinomas (Breast Cancer Res 2015;17:37)
- Most common special subtype of invasive breast carcinoma (Br J Cancer 2005;93:1046)
- Only comprises 1% of male breast carcinomas (Breast Cancer (Dove Med Press) 2017;9:337)
Mean age of diagnosis is 63.4 years, higher than that for invasive breast carcinoma of no special type (Br J Cancer 2005;93:1046)
Endogenous (lower parity, younger age at menarche and later menopause) and exogenous (hormone replacement therapy and oral contraceptives) estrogen exposure increases risk (Breast Cancer Res 2015;17:37)
- Alcohol consumption and obesity are risk factors, which may be mediated by increased levels of circulating estrogen
60% lifetime risk in women with hereditary diffuse gastric cancer syndrome (germline CDH1 mutation) (J Med Genet 2010;47:436)
- Under represented in breast carcinomas of BRCA1 carriers (2.2%) and similar proportion BRCA2 carriers (8.4%) (Cancer Epidemiol Biomarkers Prev 2012;21:134)

Sites

Breast
Can occur in axilla accessory breast tissue

Etiology

Invasiveness and loss of cellular cohesion due to abnormalities of the adherens complex, formed by cadherins and catenins (Biochim Biophys Acta 2008;1778:660)
- Majority of lobular carcinomas show loss of E-cadherin expression (Am J Surg Pathol 2010;34:1472)
- α, β and γ catenins and p120 expression can be aberrant in E-cadherin positive lobular carcinomas (Am J Surg Pathol 2010;34:1472)
Lobular carcinoma in situ is a risk factor and nonobligate precursor of invasive lobular carcinoma

Clinical features

Presents as vague findings including thickening, induration or poorly defined breast mass (Breast Dis 2008-2009;30:31)
- Overall, diagnosed at a more advanced stage than invasive breast carcinoma of no special type (Br J Cancer 2005;93:1046)
More frequently bilateral and multifocal / multicentric (Breast 2018;38:101, Ann Surg Oncol 2020;27:4711)
Leptomeningeal spread, cerebrospinal fluid, gastrointestinal tract, uterus and ovary and peritoneal metastasis more common in lobular carcinoma compared with other subtypes (AJR Am J Roentgenol 2000;175:795)

Diagnosis

Mainly histological or radiological

Radiology description

Ultrasound (Radiographics 2009;29:165)
- Hypoechoic mass with spiculated or ill defined margins and posterior acoustic shadowing
Mammography (Radiographics 2009;29:165)
- Does not consistently present as a mass (44% - 65%)
- Less commonly manifests as architectural distortion
- Microcalcification infrequent
Magnetic resonance imaging findings similar (Radiographics 2009;29:165)
- Can aid in identifying multifocal or residual disease
- Preoperative breast MRI may improve surgical planning (Breast J 2016;22:143)

Radiology images

Contributed by Dr. Mark R. Wick

Mammogram

Images hosted on other servers:

Irregular mass (mammography), hypoechoic area (ultrasound)

Prognostic factors

Older age, larger tumor size and metastatic axillary lymph node involvement are independent risk factors for survival and recurrence (Cancer 2008;113:1511)
Higher histological grade is associated with poorer outcome (Breast Cancer Res Treat 2008;111:121, Histopathology 2015;66:409)
- Independently predicts shorter disease specific survival and disease free interval
- Associated with higher stage and hormone receptor negativity
Classic type more favorable than solid, pleomorphic and other types (Cancer 2008;113:1511)
- Lower number of lymph node metastases and risk of recurrence
E-cadherin negative lobular carcinomas have a higher disease specific mortality than E-cadherin positive counterparts (Histopathology 2015;66:409)
High Ki67 index associated with risk of distant metastasis (Cancer 2008;113:1511)
Better initial outcome but worse long term (> 10 years after diagnosis) survival compared with invasive ductal carcinoma (Eur J Cancer 2008;44:73)

Case reports

55 year old woman with vague thickening and negative mammography and ultrasound (Clin Case Rep 2019;7:442)
73 year old man with invasive lobular carcinoma (Radiol Case Rep 2020;15:727)
73 year old woman with diffuse gastrointestinal metastasis 15 years after mastectomy for lobular carcinoma (Oxf Med Case Reports 2019;2019:omy133)
76 year old woman presenting with carcinoma en cuirasse (BMJ Case Rep 2017;2017:bcr2017222121)

Treatment

Mastectomy may be preferred over breast conservation due to risk of local recurrence (Breast 2003;12:23)
- Lobular carcinomas likely to have positive margins on initial excision but risk of recurrence not increased if final margins are clear (Breast Cancer Res Treat 2015;149:555)
Efficacy of chemotherapy may be limited
- Low rates of successful breast conservation after neoadjuvant chemotherapy (Ann Surg Oncol 2009;16:1606)
- Pathological complete response rate low (14%) (Am J Surg 2018;215:509)
- Adjuvant chemotherapy less effective for lobular carcinoma (Oncol Ther 2020;8:1)
Response to hormone therapy superior to invasive breast carcinoma of no special type (Eur J Cancer 2008;44:73)
Benefit from radiotherapy similar to invasive breast carcinoma of no special type (Clin Breast Cancer 2016;16:319)

Clinical images

Images hosted on other servers:

Carcinoma en cuirasse

Gross description

Can form a discrete irregular mass (BMJ Case Rep 2016;2016:bcr2016215665)
Frequently ill defined borders, due to lack of sclerotic stromal response
Not uncommonly grossly unidentifiable or is grossly underestimated, only slightly firm on palpation

Gross images

Images hosted on other servers:

Anal metastasis

Multiple foci with irregular margins

Frozen section description

Discohesive tumor cells may be difficult to identify on frozen sections, particularly when cellularity is low
Single tumor cells can be mistaken as inflammatory cells (histiocytes and lymphocytes) and vice versa
Ill defined nature of lesion increases chance of margins sent for frozen section being involved by tumor microscopically

Frozen section images

Contributed by Emily S. Reisenbichler, M.D.

Invasive lobular carcinoma

Microscopic (histologic) description

Tumor cells arranged in single files, cords and single cells (Breast Cancer Res 2015;17:12)
- Can be arranged concentrically around normal ducts, giving a targetoid appearance
Tumor cells discohesive, small, monomorphic and lacking marked atypia
- Round or notched ovoid nuclei, usually grade 1 or 2 nuclear score
- Scant cytoplasm, occasional with intracytoplasmic lumen
- Mitosis infrequent
Desmoplastic reaction and necrosis uncommon
Requires high index of suspicion for metastasis
- Single and scattered tumor cells with mild atypia requires examination on high power magnification with caution (Int J Surg Case Rep 2021;80:105612)
Other (nonclassic) patterns of lobular carcinoma
- Solid:
  - Sheets or large nests of tumor cells
- Alveolar:
  - Clusters and aggregates of ≥ 20 cells
- Tubulolobular carcinoma:
  - Tumor cells arranged in small round tubules mixed with classical lobular carcinoma
- Pleomorphic:
  - Markedly pleomorphic (nuclear size > 4 times lymphocyte or nuclear pleomorphism equivalent to high grade ductal carcinoma in situ)
  - Higher rate of hormone receptor negativity, HER2 and p53 immunohistochemistry positivity
- Histiocytoid:
  - Foamy cytoplasm resembling histiocytes
- Apocrine:
  - Abundant eosinophilic granular cytoplasm
- Signet ring

Microscopic (histologic) images

Contributed by Joshua J.X. Li, M.B.Ch.B., Gary M. Tse, M.B.B.S and Kristen E. Muller, D.O.

Tumor cells in single file

Low grade nuclei

Adjacent in situ component

E-cadherin loss

Intracytoplasmic vacuoles

Luminal A subtype

Alveolar pattern

Signet ring pattern

Solid pattern

Virtual slides

Images hosted on other servers:

Core biopsy

In situ and invasive tumor

Gastrointestinal metastasis

Cytology description

Cellularity can be low
Tumor cells arranged in chains, single files or as single cells
- Tumor cells arranged in small chains are helpful clues
Nuclear atypia mostly mild
- Nuclei round to oval and eccentric
Cytoplasm scanty with a high nuclear / cytoplasmic ratio
- Occasional intracytoplasmic vacuolations may be seen
Cytologic features can resemble mesothelial cells in effusion fluid (Diagn Cytopathol 2012;40:311)

Cytology images

Contributed by Joshua J.X. Li, M.B.Ch.B. and Gary M. Tse, M.B.B.S

Discohesive tumor cells

Mild atypia

Loose chains of cells

Intracytoplasmic vacuolation

Positive stains

Estrogen receptor (97%) and progesterone receptor (80%) (Breast Cancer Res Treat 2012;133:713)
Androgen receptor (87%) (Virchows Arch 2005;447:695)
Abnormal expression of catenins
- p120 (88%) (cytoplasmic) (Oncogene 2004;23:3272)
- Beta catenin (42% nuclear and cytoplasmic; 23% retained membranous staining) (Eur J Surg Oncol 2001;27:31)
GATA3 (97 - 100%) (Am J Surg Pathol 2013;37:1756, Ann Diagn Pathol 2015;19:6)
Mammaglobin (69%) (Ann Diagn Pathol 2015;19:6)
GCDFP-15 (52%) (BMC Cancer 2014;14:546)
Mucicarmine (highlights intracellular mucin)

Negative stains

Abnormal expression of catenins
- E-cadherin (16%) (Am J Surg Pathol 2010;34:1472, Hum Pathol 2020;102:44)
  - E-cadherin absence or reduction of membranous staining, useful but not necessary for diagnosis of lobular carcinoma
- Beta catenin (35% lost) (Eur J Surg Oncol 2001;27:31)
HER2 (1 - 11%) (Annals of Oncology 2018;29: ix1)

Molecular / cytogenetics description

Mostly luminal A subtype by gene expression profiling (Cell 2015;163:506)
- Followed by luminal B but rarely HER2 enriched or basal-like
1q gain, 16p gain and 16q loss frequent (J Pathol 2008;215:231)
- CDH1 gene located at 16q22.1 (Br J Cancer. 1997;76(9):1131-1133)
CDH1 (65%) and PIK3CA (48%) mutations common (Cell 2015;163:506)
CDH1 loss of function through truncating mutation or promoter hypermethylation combined with loss of heterozygosity at chromosome 16, resulting in loss of protein (Int J Cancer 2001;92:404, Int J Cancer. 2003;106(2):208-215, Breast Cancer Res 2015;17:12)

Sample pathology report

Left breast, mastectomy:
- Invasive lobular carcinoma (see comment)
- Comment: Sections show breast tissue with malignant cells in a diffuse and discohesive pattern, with some forming single files and small clusters. Targetoid pattern is noted. The tumor cells show mild nuclear pleomorphism with rare mitoses, corresponding to a Nottingham histological grade of I. No lymphovascular permeation is seen. The tumor measures ___cm in maximal dimension. The remaining breast tissue and nipple are unremarkable. All the resection margins are clear, with a minimal clearance of ___cm at the ___ margin. Immunohistochemical staining shows tumor cells are E-cadherin negative. The features are those of an infiltrating lobular carcinoma, classic type.

Differential diagnosis

Primary disease
- Mixed invasive breast carcinoma and invasive lobular carcinoma:
  - Presence of ductal component
  - Lobular component more commonly E-cadherin positive (92%) (Breast Cancer Res Treat 2013;138:719)
- Lobular carcinoma in situ involving sclerosing adenosis:
  - Retained lobular architecture
  - Myoepithelial cells present and can be demonstrated by immunohistochemistry
- Inflammatory infiltrates and lymphoma:
  - Lacks background lobular carcinoma in situ
  - Lymphoid cells may be more hyperchromatic and have less cytoplasm
  - No intracellular cytoplasmic vacuolation
  - Cytokeratin negative and lymphocyte markers positive
- Melanoma:
  - Lacks background lobular carcinoma in situ
  - Can display marked nuclear atypia
  - Cytokeratin negative and melanocytic markers positive
- Myofibroblastoma, epithelioid variant:
  - Well circumscribed borders
  - Lacks background lobular carcinoma in situ
  - Presence of spindle cell component
  - Cytokeratin negative
Metastatic disease
- Histiocytes and lymphocytes
- Signet ring cell carcinoma of gastrointestinal origin:
  - Significant morphological overlap
  - CDX2 positive; ER, PR, AR, GATA3, mammaglobin and GCDFP-15 negative

Board review style question #1

Which of the following germline mutations is associated with an increased risk of developing lobular carcinoma of the breast?

APC
BRCA1
BRCA2
CDH1
TP53

Board review style answer #1

D. CDH1. CDH1 encodes E-cadherin and germline mutation results in hereditary diffuse gastric cancer syndrome. No increased risk of developing lobular carcinoma of the breast is reported for germline BRCA1 and BRCA2 mutations. Germline TP53 and APC mutations result in Li-Fraumeni syndrome and familial adenomatous polyposis, which are not associated with lobular carcinoma of the breast. (Cancer Epidemiol Biomarkers Prev 2012;21:134, Breast J 2019;25:16)

Comment Here

Reference: Classic lobular carcinoma

Board review style question #2

Which of the following features is more commonly seen in classic lobular carcinoma compared with pleomorphic lobular carcinoma?

Formation of invasive tubular structures
Grade 3 (markedly pleomorphic) nuclear features
HER2 positivity
Hormone receptor positivity
TP53 mutation

Board review style answer #2

D. Hormone receptor positivity. Compared with classic lobular carcinoma, pleomorphic lobular carcinoma is more likely to be HER2 positive, hormone negative and TP53 mutated. Marked nuclear pleomorphism is a required feature of pleomorphic lobular carcinoma. Neither classic nor pleomorphic lobular carcinoma feature glandular formation. (Cell Oncol (Dordr) 2012;35:111)

Comment Here

Reference: Classic lobular carcinoma

Home > Breast > Classic